Home > Healthcare > Pharmaceuticals > Disease Specific Drugs > Parkinson’s Disease Therapeutics Market

Parkinson’s Disease Therapeutics Market Share

Report ID: GMI2724
Published Date: Jan 2021
Report Format: PDF

Download Free Sample

Parkinson’s Disease Therapeutics Market Share

Some of the major companies operating in the Parkinson’s disease therapeutics market include

Orion Corporation
Roche
AbbVie Inc.
Acadia Pharmaceuticals
Amneal Pharmaceuticals
UCB
Teva Pharmaceutical

The market leaders are engaged in several strategic collaborations, mergers, partnerships, product launches and acquisitions in order to strengthen their industrial position. Additionally, the investments made by these participants is creating opportunities for global expansion of the market.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The global market for Parkinson’s disease therapeutics had reached USD 5.15 billion in 2020 and will expand at more than 6.5% CAGR up to 2027.

The market share from COMT inhibitors segment is anticipated to register about 8.8% CAGR between 2021-2027 owing to high efficacy provided to alleviate motor symptoms in Parkinson’s patients.

The industry share from the oral administration segment was more than USD 3.41 billion in 2020 and will grow due to the ease of ingestion, pain mitigation and better patient compliance.

The U.S. held more than 94% of North America Parkinson’s disease therapeutics industry in 2020 as it is the second most common neurodegenerative disease in the country.